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Edited by Varda RotterAbstract Methyl angolensate (MA), a natural tetranortriter-
penoid, puriﬁed from Soymida febrifuga is examined for the ﬁrst
time for its anticancer properties. We ﬁnd that MA inhibits
growth of T-cell leukemia and chronic myelogenous leukemia
cells in a time- and dose-dependent manner. Accumulation of
cells in the subG1 peak, annexin V binding and DNA fragmen-
tation suggested induction of apoptosis. Besides, upregulation
of BAD (proapoptotic) and downregulation of BCL2 (antiapo-
ptotic) gene products further supported induction of apoptosis.
Loss of mitochondrial membrane potential, activation of caspase
9, caspase 3, cleavage of PARP, downregulation of Ku70/80 and
phosphorylation of MAP kinases suggested that MA could in-
duce intrinsic pathway of apoptosis in leukemic cells.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Genetic alterations in the DNAmay lead to neoplastic trans-
formations. Examples include chromosomal translocations,
deletions, insertions and duplications leading to leukemia
and lymphoma [1]. Such chromosomal aberrations may result
in upregulation of protooncogenes, downregulation of tumor
suppressor genes or fusion of genes. Examples are T-cell leuke-
mia, follicular lymphoma and chronic myelogenous leukemia
[2–5]. Such altered genes are often used as a target for many
cancer therapeutic agents.
Among cancers, leukemia is one of the most life threatening
hematological malignancies. Past twenty years have witnessed
dramatic changes in leukemia treatment paradigms. Imatinib
(Gleevac), a drug developed against the activated tyrosine
kinase to treat CML was one of the major discoveries.
Although, the success of clinical trials in identifying new agents
and treatment modalities has been signiﬁcant, current treat-
ments suﬀer from many limitations such as side eﬀects of the
drugs and drug resistance. Hence, the identiﬁcation of novel,
eﬃcient and less toxic anticancer agents remains an important
and challenging task*Corresponding author. Tel.: +9180 2293 2674; fax: +91 80 2360 0814.
E-mail address: sathees@biochem.iisc.ernet.in (S.C. Raghavan).
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.11.001The search for new pharmacologically active compounds
from plants has led to the discovery of many clinically useful
drugs [6]. Many plant-based agents are known to exert their
anticancer eﬀects by inhibiting cell proliferation and inducing
apoptosis [7]. With the rapid advances in biomedical research,
there has been a growing interest in screening natural
products. One remarkable compound in this list is methyl
angolensate (MA), which possesses a wide range of pharmaco-
logical properties. MA used in the present study is a natural
tetranortriterpenoid extracted from root callus of Soymida
febrifuga [8] with various biological eﬀects. It is known to pos-
sess antimalarial, anti-inﬂammatory, antiallergic, antifungal,
antiulcer, spasmolytic and insect antifeedant properties [9–
12]. Todate there is no study to determine the anticancer prop-
erty of MA. Herein, we report that MA can inhibit growth of
leukemic cells by inducing apoptosis.2. Materials and methods
2.1. Cell culture
Human leukemia cell lines CEM and K562 were purchased from
National Center for Cell Science, Pune, India. GM00558B cells were
a kind gift from Dr. Michael Lieber, USA. Cells were grown in RPMI
1640 (SERA LAB, UK) containing 10% FBS (GIBCO BRL, USA)
and antibiotics in appropriate conditions.
2.2. Methyl angolensate
MA used in the present study is a natural tetranortriterpenoid puri-
ﬁed from root callus ofS. febrifuga (Meliaceae) (Supplementary Fig. 1)
[8]. MA was dissolved in DMF (Sigma, USA). The maximum concen-
tration of DMF (dimethylformamide) used in the experiments was
equal to 0.05% and the same amount was used as vehicle control. In
all the experiments described herein MA was added to the cells after
24 h.
2.3. Trypan blue exclusion assay and MTT assay
Trypan blue assay was carried out to assess the eﬀect of MA on the
viability of leukemic cells as described earlier [13]. Brieﬂy, the cells
were seeded (0.75 · 105/ml) in six-well plates and diﬀerent concentra-
tions of MA (10, 100 or 250 lM or DMF) was added to the cells. After
every 24 h, cells were mixed with trypan blue (Sigma), counted under a
microscope and plotted. Cytotoxic eﬀect of MA (10, 100 or 250 lM)
on CEM and K562 cell proliferation was measured by MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide; Sigma] assay
by harvesting after 48 and 72 h [13,14].
2.4. [3H]-Thymidine incorporation into DNA
Cells were cultured in duplicates in a volume of 0.125 ml
(0.75 · 105 cells/ml) and treated with MA as described above. An aque-
ous solution of [3H]-thymidine (1 lCi, BRIT, India) diluted withblished by Elsevier B.V. All rights reserved.
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compound. After 48 h of incubation, the cells were collected, washed
in PBS (Sigma), suspended in 5% TCA (Sigma) for 30 min and centri-
fuged. Cells were then resuspended in PBS, loaded on a ﬁlter paper disc
(Sartorius, Germany) and radioactivity was measured using a liquid
scintillation beta-counter (Beckman coulterTM LS 6500, USA). Radio-
activity of the samples was expressed as cpm (counts per minute),
which was proportional to the amount of [3H]-thymidine incorporated
into the DNA of cultured cells.
2.5. Flow cytometry
K562 and CEM cells were cultured and treated with diﬀerent con-
centrations of MA. CEM cells were harvested after 12, 24, 48 and
72 h, while K562 was harvested after 72 h. The cells were processed,
stained with ethidium bromide (Sigma) and subjected to ﬂowcytometry
(FACScan, BD Biosciences, USA) using CellQuest Pro software using
excitation 488 nm laser and emission at 560/670 nm. A minimum of
10000 cells were acquired per sample and histograms were analyzed
using WinMDI 2.8 software.
2.6. Annexin V/propidium iodide staining assay and confocal microscopy
The early and late apoptotic cells were identiﬁed and quantitated
using annexin V-FITC apoptosis detection Kit (Santacruz, USA).
After culturing CEM and K562 cells for 72 h with MA (100 lM and
250 lM), cells were collected, washed and resuspended in 1 · binding
buﬀer (HEPES–NaOH 10 mM pH 7.4, 1.4 M NaCl and 25 mM CaCl2)
at a concentration of 1 · 106 cells/ml. Annexin V-FITC (0.2 lg/ll) and
PI (0.05 lg/ll) were added and incubated for 10 min. Cells were then
subjected to FACS analysis (FACScan) using CellQuest pro software
at an excitation 488 nm laser and emission at 530 nm. At least 10000
events were recorded for each sample and represented as dot plots.
Confocal ﬂuorescence microscopy was performed to visualize the
apoptotic cells generated by MA. The CEM and K562 cells after
72 h of MA treatment were incubated with annexin V-FITC and PI
as described above. The cells were then observed under an inverted
confocal laser scanning microscope (Ziess LSM 510 MK4, Germany).
2.7. Mitochondrial membrane potential
Alterations in mitochondrial membrane potential (DWm) were ana-
lyzed by ﬂow cytometry using the (DWm)-sensitive dye JC-1 (5,5 0,6,6 0-
tetrachloro-1,1 0,3,3 0-tetraethylbenzimidazolcarbocyanine iodide;
Calbiochem, USA) [15]. Brieﬂy, cells were harvested, washed, resus-
pended in PBS and incubated with JC-1 (0.5 lM) at 37 C for 15 min.
Cells were then washed in PBS and analyzed by ﬂow cytometry using
CellQuest Pro software using an excitation 488 nm laser and emission
at 530/30, 580/610 nm. JC-1 monomers emit at 530 nm (FL-1 channel)
and J-aggregates emit at 590 nm ((FL-2 channel). 10000 cells were ac-
quired per sample. While analyzing appropriate gates were applied.
2,4-Dinitrophenol-treated cells (2,4-DNP; positive control) were used
for compensation [16].
2.8. DNA fragmentation assay
Apoptotic degradation of DNA was analyzed by agarose gel electro-
phoresis. Brieﬂy,CEMorK562 cellswere culturedwith diﬀerent concen-
trations (10, 100 and 250 lM) of MA for 72 h. Cells were harvested and
genomic DNA was extracted using standard protocols [17]. The DNA
samples were run on a 1% agarose gel and was visualized by ethidium
bromide staining and photographed under ultraviolet illumination.
2.9. Immunoblotting
Cell lysate was prepared from MA treated CEM (100 lM for 24, 48
and 72 h) and K562 (100 lM for 72 h) cells. For immunoblot analysis,
30–40 lg of protein was loaded on a SDS–PAGE (8–10%), transferred
to PVDF membrane (Millipore, USA) and probed with appropriate
primary and secondary antibodies (Santacruz, USA). The blot was
developed using chemiluminescent solution (ImmobilonTM western,
Millipore, USA) and scanned by gel documentation system (LAS
3000, FUJI, JAPAN). Blots were stripped subsequently as per stan-
dard protocol and reprobed with anti-tubulin.
2.10. Statistical analysis
The results are expressed as the mean plus or minus standard error.
All analyses were performed with the GraphPad software using one-way ANOVA followed by Tukey–Kramer Multiple Comparison Test.
Statistical signiﬁcance was considered at P < 0.05.3. Results
3.1. MA induces cytotoxicity in leukemic cells in a dose- and
time-dependent manner
In order to evaluate the cytotoxic eﬀect of MA on growth of
leukemic cells, we used trypan blue assay. Leukemic cell lines,
CEM (T-cell leukemia) and K562 (chronic myelogenous leuke-
mia) were treated with 10, 100 or 250 lM of MA. The cells
without addition of compound served as control. Since the
compound was dissolved in DMF, the cells with DMF were
used as vehicle control. Following addition of compound, cells
were counted at intervals of 24 h until the control cells attained
stationary phase. Results showed that cell growth was aﬀected
in both the cell lines with increase in time (Fig. 1A–D). The ef-
fect was limited when 10 lM MA was used. However, concen-
trations of 100 and 250 lM resulted in increased cell death
(Fig. 1A–D). In the case of both cell lines, growth of control
cells and DMF treated cells were comparable (Fig. 1A and
C). The IC50 of MA was approximately 100 lM, at 72 h of
treatment. These results suggest that MA induces cytotoxicity
in human leukemic cells in a dose- and time-dependent man-
ner.
The cytotoxicity induced by MA on proliferation of leuke-
mic cells was further veriﬁed using MTT assay. CEM and
K562 cells treated with 10, 100 and 250 lM of MA were har-
vested after 48 or 72h and were subjected to MTT assay
(Fig. 1E and F). Results showed that cell viability was aﬀected
upon treatment with MA at 100 and 250 lM, especially after
72h. These results further suggest that MA induces the cyto-
toxicity. However, when a normal lymphoblastoid cell line,
GM00558B was analyzed by MTT assay following MA treat-
ment we could not ﬁnd any signiﬁcant eﬀect on cell survival
(Supplementary Fig. 2).
3.2. MA aﬀects the proliferation of human leukemic cells
Since above studies suggested that MA aﬀects the viability of
the cells, we were interested to know whether MA could inhibit
cell division. To test this, we cultured CEM and K562 cells in
the presence of [3H]-thymidine following the addition of MA.
Results showed that MA treatment (100 and 250 lM) for 48 h,
reduced incorporation of [3H]-thymidine drastically (Fig. 2).
These results suggest that MA aﬀects the cell viability by inhib-
iting cell division probably by interfering with DNA replica-
tion. However, it is also possible that in addition to its eﬀect
on cell division, it could also induce apoptosis.
3.3. MA alters cell cycle progression
Since [3H]-thymidine incorporation assay suggested an eﬀect
of MA on cell division, we performed FACS analysis to deter-
mine the eﬀect on cell cycle progression. K562 cells were
stained with ethidium bromide after 72 h of treatment with
MA (10, 100 and 250 lM) and subjected to FACS. Histogram
of vehicle treated cells showed a standard cell cycle pattern,
which includes G1 and G2 separated by S phase (Fig. 3A).
The subG1 phase (mostly dead cells) was not prominent. Inter-
estingly, upon addition of MA, a concentration dependent
change was observed in the cell cycle pattern (Fig. 3A and
B) leading to accumulation of cells in subG1 and decline of
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Fig. 1. Cytotoxicity analysis of methyl angolensate (MA) in leukemic cell lines. (A–D) Evaluation of cell viability using trypan blue assay following
MA treatment. CEM (A and B) or K562 (C and D) cells were treated with 10, 100 and 250 lM of MA or DMF (vehicle control). In the case of
‘‘control’’ neither MA nor DMF was added. Cells were harvested, trypan blue stained and counted every 24 h until it reached stationary phase. (E
and F) Determination of % cell viability by MTT assay in CEM (E) and K562 (F) cells. Cells were cultured with 10, 100 and 250 lMof MA or vehicle
control for 48 h and 72 h. The percentage of cell viability was calculated considering DMF treated cells as 100% and plotted with representation of
error bars.
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comparable when CEM cells were used for similar analysis
after 72 h of MA treatment (Fig. 3F). However, the extent of
cell death in CEM cells was much higher. It is important to
point out that like K562, in CEM also we could not ﬁnd any
evidence for cell cycle arrest. Thus, the results obtained, con-
ﬁrmed our earlier observation of MA induced cytotoxicity.
Since the analyses performed were after 72 h of MA treat-
ment, we were interested to study possible induction of check-
points before 72 h. We have used CEM for this purpose as it
was more sensitive in the above study. Synchronized CEM
cells were treated with MA (100 and 250 lM) for 12, 24, 48
and 72 h. Results showed a time- and dose-dependent accumu-
lation of subG1 population of cells, which is a hall mark of
apoptosis (Fig. 3C–F). However, even in this case we couldnot ﬁnd any evidence for cell cycle arrest. These ﬁndings
indicate that at the ranges of concentration studied, the anti-
proliferative eﬀect of MA on leukemic cells could be attributed
primarily to the induction of apoptosis, with less or no contri-
bution from cell cycle arrest.
3.4. MA induce translocation of phosphatidyl serine of cells to
outer membrane
The induction of apoptosis was further studied and quanti-
ﬁed by performing annexin V-FITC/PI staining. CEM and
K562 cells were harvested after treatment with MA for 72 h
(100 and 250 lM) and used for double staining followed by
cytometric analysis (Fig. 4A and B). Dot plot results of
MA on K562 cells showed that at a concentration of
100 lM, about 28.5% of cells were in early apoptotic stage
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K.K. Chiruvella et al. / FEBS Letters 582 (2008) 4066–4076 4069(stained only by annexin V-FITC) (Fig. 4B), while about 25%
of the cells were in late apoptotic stage (stained by annexin V-
FITC and PI), which was 6.3 times higher than that of DMF
control (Fig. 4B). At a concentration of 250 lM this was ob-
served to be 24.7% (1.6 times higher than control) and 30.4%
(7.6 times higher than control), respectively (Fig. 4B). Com-
parable results were obtained when CEM cells were used
for the study (Fig. 4A). These results showed that MA in-
duces translocation of phosphatidyl serine leading to apopto-
sis. The annexin V-FITC/PI stained cells indicate that in such
cells extensive cell membrane damage has occurred, resulting
in the nuclear staining. These conclusions were further veri-
ﬁed by confocal microscopy of above stained cells. The re-
sults showed that most of the CEM or K562 control cells
(DMF treated) were negative for annexin V-FITC and PI
(Fig 4C, a and c). At 100 lM concentration of MA, we could
see cells stained by annexin V-FITC (green colored rim) and
intact nuclei (data not shown) or cells stained by both annex-
in V-FITC (green color) and PI (red color) (Fig 4C, b and d).
These results suggest a total disruption of cell membrane and
further damage to the chromosomal DNA upon treatment
with MA.
3.5. MA changes the mitochondrial membrane potential
The loss of mitochondrial membrane potential (MMP) pre-
cedes the gross morphological changes associated with apopto-
sis. To explore the eﬀect of MA on the mitochondrial
membrane potential, CEM cells were cultured in presence of
compound (100 lM), harvested after 24, 48 and 72 h and usedfor ﬂow cytometric analysis following staining with the ﬂuores-
cent probe JC-1. Representative scattergrams for red-FL2
(indicator of an intact mitochondrial membrane potential)
and green-FL1 (indicator of mitochondrial membrane poten-
tial collapse) ﬂuorescence are presented (Fig. 5). Results
showed that DMF treated cells, mostly exhibited red ﬂuores-
cence indicating an intact mitochondrial membrane potential
(Fig. 5A). Upon addition of MA, the number of cells showing
green ﬂuorescence increased with time, as seen in the case of
positive control 2,4-DNP (Fig. 5A and B). This suggests that
addition of MA disrupted the mitochondrial membrane poten-
tial in a time-dependent manner resulting in cytosolic accumu-
lation of monomeric JC-1.
3.6. MA induces DNA fragmentation
Since above studies suggested the activation of apoptosis in
MA treated cells, we were interested to know the extent of
DNA breaks. CEM and K562 cells treated with 10, 100, or
250 lM of MA were harvested after 72 h and used for DNA
fragmentation assay. The results showed fragmentation of
the chromosomal DNA leading to a smear in the lanes in
which cells were treated with MA (Supplementary Fig. 3). Such
breakage was more when the cells were treated with 100
or 250 lM. The intensity of smear increased with the dose
(Supplementary Fig. 3A and B). Preliminary data using comet
assay also provided evidence of DNA fragmentation (data not
shown). These results in conjunction with annexin V-FITC
staining further suggest that MA induces fragmentation of
chromosomal DNA leading to apoptosis.
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Since we have seen evidence for activation of apoptosis by
MA, we tested speciﬁc proteins related to apoptosis by western
blot analysis. For initial screening, the cell lysate was prepared
from K562 cells after treating with MA for 72 h. Immunoblot
analysis showed downregulation of the antiapoptotic protein,
BCL2, when compared with control (Supplementary Fig. 4A).
Immunoblot analysis against BAD, a proapoptotic protein,
showed upregulation (Supplementary Fig. 4B). These preli-
minary results further conﬁrm the activation of apoptosis
upon treatment with MA. We also noted MA induced down-
regulation of DNA double-strand break (DSB) repair pro-
teins, Ku70 and Ku80 (Supplementary Fig. 4C).
Next we were interested in testing the changes in the expres-
sion levels of apoptosis related proteins in a time-dependent
manner. Since, MA was maximally eﬀective against CEM cells,
it was used for further studies. Lysates were prepared after 24,
48 and 72 h of MA treatment and used for immunoblotting.
Lysate prepared after 72 h of treatment with DMF was used
as control. Results showed that BCL2 expression was down-
regulated, in a time-dependent manner (Fig. 6A). It is interest-
ing to point out that upon treatment with MA, within 24 h,
expression of BCL2 was upregulated and then down regulated
by 48 and 72 h. When the blot was reprobed with BAD, we
found initial downregulation at 24 and 48 h followed by upreg-
ulation in its expression (Fig. 6A). These ﬁndings further con-
ﬁrm the above results.
Poly (ADP-ribosyl) polymerase (PARP) is a single strand
break repair enzyme known to be cleaved by caspase 3. Uponimmunoblotting using anti-PARP, we found a 89 kDa band
corresponding to the cleaved product. The cleaved product
was maximum after 24 h of MA treatment (Fig. 6B), which re-
duced when the incubation time was prolonged to 48 and 72 h,
respectively (Fig. 6B). Since we could see PARP cleavage, we
were interested in testing the expression of caspases 3 and 9.
Our results showed activation of procaspase 3, at 24 h of treat-
ment (Fig. 6B). However, extended treatment lead to the
downregulation of procaspase 3, which could be the result of
its cleavage into active caspase 3 (Fig. 6B). Since the antibody
used against procaspase 3, could not recognize its cleaved
product we were unable to detect the cleaved caspase 3 prod-
ucts. However, when the blot was probed with caspase 9 we
could see a low level of caspase 9 after 24 h in a time-
dependent manner (Fig. 6C). In this case also we could observe
caspase 9 cleaved product, which is again maximum at 24 h.
Reprobing with anti-tubulin antibody, the loading control,
conﬁrmed that the amount of protein loaded was equal in all
experiments (Fig. 6B and C). Therefore, immunoblot analysis
suggests that MA induces activation of proapoptotic proteins
and downregulation of antiapoptotic proteins to induce apop-
tosis in CEM. Further, activation of caspase 9 and 3 followed
by PARP cleavage suggest that MA might be inducing the
intrinsic apoptosis pathway to trigger cell death.
By using western blot analysis we found that MA treatment
did not lead to activation of p53 in CEM (Fig. 6D). Ku70 and
Ku80 are DNA end binding proteins involved in non-homolo-
gous end joining, a pathway involved in DNA DSB repair in
mammalian cells. Following western blot analysis we could
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(Fig. 6D). These results, suggest that MA treatment led to
the downregulation of Ku proteins and hence promotes apop-
tosis. Further we ﬁnd that the levels of replication related pro-
tein, p-histone H3 reduced upon treatment with MA from 24 h
onwards (Fig. 6E); however, robust expression was seen in the
control (Fig. 6E). These results indicated that histone H3, (a
histone normally phosphorylated at M phase) is not phosphor-
ylated when cells were treated with MA. Further studies are re-
quired to understand the importance of this observation.
3.8. MA aﬀects the expression of MAPK family proteins
Many lines of evidence have implicated the MAP kinase
family molecules in the regulation of apoptosis. To explore
the possible pathways by which MA induced apoptosis in
CEM cells, we determined if any of the MAP kinase pathways
were activated after the treatment of cells using immunoblot-
ting. Results showed that MA could activate ERK1/2 by phos-
phorylation within 24 h of treatment (Fig. 7). However,prolonged treatment led to the reduction in the level of acti-
vated ERK1/2. These results suggest that MA leads to the
phosphorylation of ERK1/2 in CEM cells immediately follow-
ing treatment. Interestingly, MA did not induce phosphoryla-
tion of ERK1/2 in K562 cells (data not shown). Whether this
diﬀerence contributes to the greater sensitivity of CEM cells
to MA induced apoptosis remain to be determined. Our study
also showed that p-JNK, p-MEK1/2 (Fig. 7) and p-threonine
(data not shown) were activated in CEM upon treatment with
MA. These results suggest that MA triggers a cascade of sig-
naling events in order to activate various downstream apopto-
tic proteins, ﬁnally leading to cell death.4. Discussion
Many medicinal plants from India have been routinely used
for treating diseases in ‘‘Ayurveda’’ mostly without side
eﬀects. However, one major drawback is that the molecular
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4072 K.K. Chiruvella et al. / FEBS Letters 582 (2008) 4066–4076mechanism of action of such plants is largely unknown [18]. In
the present study we have used a natural compound, methyl
angolensate, to study its anticancer properties. We found that
MA is toxic to both T-cell leukemia and chronic myelogenous
leukemia cells. Although MA induced cytotoxicity in these
cells, the IC50 value was about 100 lM, which is higher than
most of the synthetic compounds. This is not surprising since
MA is a natural product. Infact, previous reports on other
compounds have used similar doses [19–23].
Various terpenoids are attractive natural compounds for the
treatment of cancer as they can overcome the drug resistance
[24,25]. Since, MA is a plant tetranortriterpenoid [8], the ob-
served MA induced cytotoxicity seen in leukemic cells is of
importance. Previous studies have shown that MA possesses
chemopreventive properties with various biological eﬀects[9–12]. However, this is the ﬁrst study to test the anticancer
properties of MA.
Treatment of leukemic cells with MA resulted in a dose-
dependent generation of apoptosis-speciﬁc morphological
changes. Further, they exhibited loss of cell viability, subG1
phase accumulation and DNA fragmentation. The labeling
of cells with annexin V-FITC/PI showed disruption in the
integrity of the cell membrane conﬁrming the apoptotic status
[26]. Changes were also observed in the membrane potential
and expression of proteins related to apoptosis. These results
further suggest that the reduction in cell viability observed in
leukemic cells following MA treatment was due to apoptosis.
However, the major questions are what would be the apoptotic
pathway through which MA induces cytotoxicity and its
signaling mechanism?
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leading to cell death, which is regulated through BCL2 family
proteins comprising antiapoptotic (BCL2, BCL-XL) and proa-
poptotic members (BAX, BAD) [27,28]. To test the roles of
these proteins, we measured their expression. It was noted that
the levels of BCL2 and BAD were altered leading to an in-
crease in the antiapoptotic/proapoptotic proteins ratio inaccordance with other studies [29,30]. Hallmarks of the apop-
totic process include the activation of caspases. We have noted
that at early time points (24 h), the expression of caspase 9 and
3 increased. However, prolonged treatment with MA led to
their cleavage resulting in their activation. PARP is shown to
have a role in DNA damage induced apoptosis and is the ma-
jor targets of caspase 3 [31,32]. We found that MA treatment
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of caspase 3. Hence, our results suggest that MA triggers acti-
vation of intrinsic pathway of apoptosis.
If MA mediated cell death is through intrinsic pathway of
apoptosis, one would anticipate a change in the mitochondrial
membrane potential leading to the release of cytochrome c.
Our studies using JC-1 staining indeed indicated a loss of
MMP further supporting the activation of intrinsic pathway.
Thus, our results are in accordance with the earlier observation
suggesting that high ratio of BAX to BCL 2 could lead to col-
lapse of mitochondrial membrane potential and apoptosis [33].
The observed reduction in the expression levels of Ku70 and
Ku80 proteins when treated with MA is of interest. Since these
proteins are involved in the DNA DSB repair, downregulation
of Ku70 and Ku80 are expected to promote apoptosis as
NHEJ pathway is less eﬃcient [34–36]. It has been suggested
that Ku proteins might regulate the apoptotic cell death, deg-
radation of which may help to prevent the inappropriate repair
of fragmented nuclear DNA during apoptosis [37]. A compa-
rable reduction in the level of Ku70 was reported when human
colorectal cancer cells were treated with justicidine [38]. The le-
vel of Ku decreased in a time-dependent manner (Fig. 6D) and
this was associated with proteolytic cleavage of PARP, which
is a substrate of caspase 3. Similar results were obtained in ble-
omycin, vincristine- or adriamycin-treated HeLa cells [39].
These results suggest that the Ku protein level decreased in
K562 and CEM due to proteolytic cleavage after treatment
of MA and thereby the appropriate repair of fragmented nu-
clear DNA would be prevented during apoptosis, leading to
programmed cell death. However the role of p53 in mediating
apoptosis was ruled out since CEM express non-functional
mutant p53 [40,41] and K562 cells lack expression of p53 [42].
Many lines of evidence have implicated the MAP kinase
family molecules in the signaling of apoptosis. In mammalian
cells distinct MAPK members have been identiﬁed, which
include extracellular signal-regulated kinases (ERKs), stress-
activated protein kinases (SAPKs)/c-Jun NH2-terminal
kinases (JNKs), and the p38 kinases [43–45]. Various phyto-
chemicals, including epigallocatechin-3-gallate, resveratrol,
arucanolide etc. [46–48] have been shown to modulate the sig-
naling pathways of MAPKs, leading to growth inhibition andcell death. Immunoblotting studies of ERK1/2 showed upreg-
ulation of its phosphorylated form in CEM cells within 24 h of
treatment. This suggests that MAP kinase pathway might be
activated by MA, to mediate signals resulting in apoptosis.
However, prolonged incubations of CEM cells with MA
(48 h and 72 h) led to the downregulation of phosphorylated
ERK1/2. It has been proposed that the prolonged activation
of the MAP kinase is accompanied by the translocation of
the enzyme to the nucleus [49] with subsequent alterations in
the gene expression. Accordingly, ERK1/2 may be involved
in the signal transduction of MA induced apoptosis [50]. Inter-
estingly, MA did not induce phosphorylation of ERK1/2 in
K562 cells (data not shown). However, whether this diﬀerence
contributes to the greater sensitivity of CEM cells to MA in-
duced apoptosis remains to be determined.
Hence, for the ﬁrst time, we experimentally demonstrate that
MA possesses anticancer properties. Our data suggest that MA
induces apoptosis by triggering the intrinsic pathway. In sum-
mary, MA induces DNA damage causing downregulation in
the expression of antiapoptotic proteins like BCL2 and upreg-
ulation of proapoptotic proteins like BAD leading to an altered
antiapoptotic–proapoptotic ratio (Supplementary Fig. 5).
Downregulation of BCL2 leads to the loss of mitochondrial
membrane potential, causing the release of cytochrome c. This
activates caspase 9, which in turn results in the activation of
caspase 3. This leads to the cleavage of PARP, which hampers
its ability to carry out poly-ADP-ribosylation of various pro-
teins involved in DNA repair such as Ku70 and Ku80, causing
the failure of repair of damaged DNA. This will lead to degra-
dation of cellular DNA. Simultaneously, caspase 3 could acti-
vate nucleases, which will also cause the degradation of the
nuclear DNA leading to apoptosis. Further, MA treatment re-
sulted in phosphorylation of signaling molecules such as
ERK1/2, JNK and MEK 1/2 implying their role in apoptotic
signal transduction ( Supplementary Fig. 5). However, more
studies are required to unravel the signaling mechanism in-
duced by MA. Hence, the present study provides a new insight
of MA serving as a potential leukemic therapeutic agent.Acknowledgements: We thank members of the SCR laboratory for
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